Description: This document is a Request for Proposals (RFP) outlining a proposal request on the impact of the U.S. drug abuse epidemic on mortality, focusing on opioids. It provides details on the background, purpose, research objectives, proposal requirements, selection process, and conditions for submitting a proposal.

Description: Learn about the industrial practice for constructing the mortality table from 0 to 1 through journeys in Hong Kong and Singapore, including key takeaways. Hear speakers share their biggest challenges during their process, how they resolved them, and discover the most common technical issues faced in conducting the mortality tables.

Description: A Request for Proposals (RFP) for research studies on the impact of climate change and catastrophes on the U.S. health infrastructure. It outlines the background, objectives, submission requirements, and selection process for potential researchers.

Description: U.S. News & World Report Ranks Actuary in Top 10 of 100 Best Jobs of 2024 - January 25, 2024

Description: To inform and educate stakeholders for health plans and insurers on novel ways to optimize reinsurance structures to meet capital related goals and boost RBC and liquidity ratios. In lieu of traditional market-based financial instruments involving equity and/or debt, a quota share transaction can be used with potentially far more attractive terms and achieving essentially the same result.

Description: Join a discussion on the tax implications for direct writers ceding annuity blocks for both onshore and offshore reinsurance arrangements. Get an introduction to the tax consequences of the risk transfer of annuity features and guarantees to reinsurers to reinsurers that are U.S.-based and not U.S. domiciled.

Description: Speakers provide insights for adjusting historical and future mortality for COVID-19. Recent Society of Actuaries research examining historical U.S. population mortality by socioeconomic category and methodologies for removing the impact of COVID-19 from mortality rates will be presented. Additionally, results from an expert opinion survey on COVID-19 and future mortality will be discussed. Thoughts on how companies are utilizing external and internal sources to modify mortality assumptions/models for COVID-19 will be shared.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: Discuss population mortality improvement trends in the U.S. This will include analysis of cause of death data and trends in mortality pre-pandemic and during the pandemic. We will also discuss ways to think about translating population mortality improvement to an insured population.Learning outcomes includea better understanding of the drivers of recent mortality improvement and insights on how to create a company view on mortality improvement.